AU Patent

AU2010295307B2 — Phentermine liquid dosage form

Assigned to Pharmacorp Pty Ltd · Expires 2014-11-20 · 11y expired

What this patent protects

The invention provides a pharmaceutical composition liquid dosage form of Phentermine, said dosage form including a liquid carrier and suspended or dissolved therein one or more pharmaceutically active ingredient selected from Phentermine, salts and bases thereof, and a pro-drug …

USPTO Abstract

The invention provides a pharmaceutical composition liquid dosage form of Phentermine, said dosage form including a liquid carrier and suspended or dissolved therein one or more pharmaceutically active ingredient selected from Phentermine, salts and bases thereof, and a pro-drug thereof. The invention extends to a method of administering Phentermine to an obese patient in need thereof and for appetite suppression or related conditions.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010295307B2
Jurisdiction
AU
Classification
—
Expires
2014-11-20
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacorp Pty Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.